New restrictions on celecoxib (Celebrex) use and the withdrawal of valdecoxib (Bextra)
Open Access
- 10 May 2005
- journal article
- Published by CMA Impact Inc. in CMAJ : Canadian Medical Association Journal
- Vol. 172 (10), 1299
- https://doi.org/10.1503/cmaj.050456
Abstract
No abstract availableThis publication has 2 references indexed in Scilit:
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac SurgeryNew England Journal of Medicine, 2005